<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210530051443N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-09-15</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>The effect of using disease management application on elderly caregivers with Parkinson's disease</public_title>
      <acronym></acronym>
      <scientific_title>The effect of using disease management Smartphone based application on perceived stress and self-efficacy of caregivers of the elderly with Parkinson's disease</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-07-05</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/56635</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: Sampling will be done randomly in the "available" type and the participants will be assigned to two groups randomly using the block randomization method. Blocking is usually done to balance the number of specific samples. One of the studied groups is used in this study, blocks are randomly selected using SPSS software, Blinding description: Blinding is one-way blind method in which patients are first randomly assigned to two groups, and the researcher when assigning individuals to two groups will do randomly.
  In the data analysis stage, the groups will enter the software as A and B and the analyzer will be unaware of the groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Parkinson's disease.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: First, the application is prepared. Application capabilities include teaching various items such as name, mode of action, how to better use drugs, drug interactions, doses, side effects, management and non-drug therapies, proper exercise, disease risk symptoms, proper nutrition and food, medication reminders Reminders to see a doctor, the ability to communicate with the treatment team, etc. are important cases for the next visit to the doctor. Then a meeting will be held with research units to teach how to use the application, which will be held in accordance with the opinions of caregivers in the faculty or clinic. After learning how to use, the application will be installed on their mobile phones. The researcher gives his / her phone to the research units so that if he / she has any questions, he / she can answer them. Also, during the research, the research units will be contacted at least once a week regarding the use of the application and possible problems. In order to prevent the publication of content between the two groups, a special code has been considered for each person using the application, so that the caretaker will not be able to install this application on other devices without prior notice. Intervention 2: Control group: The trainings are routinely provided based on the contents of the application. The researcher gives his / her phone to the research units so that he / she can answer any questions. Also, during the research, at least once a week, the research units will be contacted regarding the use of educational items and possible problems.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Caregiver questionnaires can be shared after deleting the names at the end of the study.

When:
Access period starts 6 months after the results are published

To whom:
Only people who work in universities and should be doing research related work.

Conditions:
Analyzes have no limits. Researchers must make a written commitment that the information will not be published anywhere and that the results of the analysis will be published with the permission of the principal investigator. The researcher must also provide evidence of his or her involvement in ongoing research.

Where to obtain:
In order to receive information, the request must be sent in writing to the email address ValizadehN@mums.ac.ir.

How to obtain:
After receiving the request in the mentioned e-mail, MIT.and information will be provided to her after one month.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hossein Sanaei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Danesh va Salamat Town, between Shahid Javan and Shahid Square, Shahid Fakuri Boulevard, Mashhad</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>99191-91778</zip>
        <telephone>+98 51 4346 3273</telephone>
        <email>sanaeih18@yahoo.com</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Najmeh Valizadeh Zare</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Danesh va Salamat Town, between Shahid Javan and Shahid Square, Shahid Fakuri Boulevard, Mashhad</address>
        <city>mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>99191-91778</zip>
        <telephone>+98 51 3879 5031</telephone>
        <email>ValizadehN@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Elderly caregiver: Spend the most time caring for the elderly with Parkinson's
Elderly caregiver: Having a smart phone
Elderly caregiver: 18 to 60 years old
Elderly caregiver: No history of mental disorders
Elderly caregiver: literacy
Elderly caregiver: Do not use anti-anxiety and sedative drugs
Elderly: Age over 70 years
Elderly: The definitive diagnosis of Parkinson's has been confirmed by a neurologist
Elderly: Existence of moderate to high cognitive status according to MSE questionnaire
Elderly: No history of stroke
Elderly: No underlying mental illness</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Caregiver exclusion criteria: Acute debilitating disease during the study
Caregiver exclusion criteria: dissatisfaction with the continuation of the study
Elderly Exclusion Criteria: hospitalization
Elderly Exclusion Criteria: Change of the elderly caregiver
Elderly Exclusion criteria: Acute problems such as heart attacks and strokes, debilitating infections, heavy bleeding, any other disease that reduces the patient's level of consciousness
Elderly Exclusion Criteria: Transfer to a nursing home</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G20</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Parkinson's disease</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: First, the application is prepared. Application capabilities include teaching various items such as name, mode of action, how to better use drugs, drug interactions, doses, side effects, management and non-drug therapies, proper exercise, disease risk symptoms, proper nutrition and food, medication reminders Reminders to see a doctor, the ability to communicate with the treatment team, etc. are important cases for the next visit to the doctor. Then a meeting will be held with research units to teach how to use the application, which will be held in accordance with the opinions of caregivers in the faculty or clinic. After learning how to use, the application will be installed on their mobile phones. The researcher gives his / her phone to the research units so that if he / she has any questions, he / she can answer them. Also, during the research, the research units will be contacted at least once a week regarding the use of the application and possible problems. In order to prevent the publication of content between the two groups, a special code has been considered for each person using the application, so that the caretaker will not be able to install this application on other devices without prior notice.</i_keyword>
      <i_keyword>Control group: The trainings are routinely provided based on the contents of the application. The researcher gives his / her phone to the research units so that he / she can answer any questions. Also, during the research, at least once a week, the research units will be contacted regarding the use of educational items and possible problems.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Perceived stress is the body's response to a change that requires adaptation or a physical, mental, or emotional response; stress can be triggered by any stressful factor or stimulus. The caregiver's score is based on Cohen's Perceived Stress Inventory (PSS), which has 14 questions and is used to measure perceived stress in the past month. A high score indicates high stress and a low score indicates low stress. Timepoint: This variable will be measured first and then one month after the start of the study. Method of measurement: Perceived Stress Scale.</prim_outcome>
      <prim_outcome>Self-efficacy is a degree of a person's sense of mastery over the ability to perform the desired actions. Practical definition: The score obtained by the self-efficacy questionnaire with 35 questions and the higher the score, the higher the self-efficacy indicator is considered. This questionnaire has five dimensions. These include caregiver self-efficacy in gathering information about treatment, symptoms and health care, gaining support, responding to problem behaviors, managing home, personal and medical care, and controlling distressing thoughts about care. Timepoint: This variable will be measured first and then one month after the start of the study. Method of measurement: Revised Caregiving Self-Efficacy Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-03-01</approval_date>
        <contact_name>Ethics Committee of the School of Nursing and Midwifery - Mashhad University of Medical Sciences</contact_name>
        <contact_address>Bojmehran village, Shafa alley, Mohammad Hassan Sanaei house neyshbour Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
